【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, August 2013 14
2.2.1 Amgen Receives Antitrust Approval to Acquire Onyx Pharma for up to US$10.4 Billion 14
2.2.2 Celgene Completes Public Offering of Notes for US$1.5 Billion 15
2.2.3 Sanofi Prices Public Offering of Bonds Due 2020 for US$1.3 Billion 16
2.2.4 Akorn to Acquire Hi-Tech Pharmacal for US$640 Million 16
2.2.5 Pharmstandard Completes Acquisition of Bever Pharma for US$590 Million 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, August 2013 20
3.1.1 Top M&A Deals in August 2013 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2013 – August 2013 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2013 24
3.2.1 Top Equity Offering Deals in August 2013 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2013 – August 2013 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2013 29
3.3.1 Top PE/VC Deals in August 2013 30
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2013 31
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2013 33
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, March 2013-August 2013 35
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2013-August 2013 36
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2013 37
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2013 37
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2013 – August 2013 39
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2013 41
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2013 42
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2013 – August 2013 43
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2013 – August 2013 45
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2013 – August 2013 46
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2013 – August 2013 48
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2013 50
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2013 50
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2013 52
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, August 2013 54
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2013 54
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2013 54
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2013 – August 2013 55
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2013 – August 2013 57
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2013 – August 2013 59
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), March 2013 – August 2013 61
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 63
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, August 2013 63
6.1.1 Oncology – Deals of the Month 65
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, August 2013 67
6.2.1 Central Nervous System – Deals of the Month 68
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, August 2013 70
6.3.1 Immunology – Deal of the Month 71
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, August 2013 72
6.4.1 Infectious Diseases – Deals of the Month 74
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, August 2013 75
6.5.1 Metabolic Disorders – Deal of the Month 76
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, August 2013 77
6.6.1 Cardiovascular – Deal of the Month 78
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, August 2013 79
6.7.1 Gastrointestinal – Deal of the Month 80
7 Deal Summary by Geography 81
7.1 Pharmaceuticals & Healthcare, North America Deals, August 2013 81
7.1.1 North America – Deals of the Month 82
7.2 Pharmaceuticals & Healthcare, Europe, Deals, August 2013 84
7.2.1 Europe – Deals of the Month 85
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, August 2013 87
7.3.1 Asia-Pacific – Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, August 2013 90
7.4.1 Rest of the World – Deals of the Month 91
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 92
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, March 2013 – August 2013 92
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, March 2013 – August 2013 94
9 Further Information 96
9.1 Methodology 96
9.2 About GlobalData 97
9.3 Disclosure information 98
9.4 Disclaimer 98
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：August 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals
■ 発行日：2013年9月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403162245
■ 調査対象地域：グローバル
- 加工スナックの世界市場：押出スナック、トルティーヤ・チップス、ポーク・スクラッチングAbout Processed Snacks Processed snacks are products that are less perishable and more portable than prepared foods. Though there are many variants in terms of the ingredients used, the processed snacks market can be divided into three categories: extruded snacks, tortilla chips/corn chips, and pork scratchings. Processed snacks are eaten in between meals. Their consumption has increased as breakf …
- 経皮薬物送達（Transdermal Drug Delivery）市場及びパイプラインインサイトTransdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is placed on the skin for delivering a specific dose of medication through t …
- French HIV/AIDS Diagnostics Market 2014: Hospitals, Blood Banks, Commercial Labs–Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT ProceduresComplete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.Summary This report presents detailed analyses of the AIDS diagnostics market in France. The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals …
- 2014年戦略提言：アメリカの薬物乱用ポイントオブケア（POC）検査市場This new 165-page report from Venture Planning Group contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop eff …
- Albaconazole (Dermatophytic Onychomycosis)：市場予測と分析（～2022）Albaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Albaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022”. Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection can involve the nail unit (nail matrix, nail bed, or nai …
- 世界の商用航空機用情報システム市場動向（2012-2016）TechNavio's analysts forecast the Global Commercial Airports Information Systems market to grow at a CAGR of 6.32 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing global air traffic. The Global Commercial Airports Information Systems market has also been witnessing rapid technological advancements. However, the increasing cost of airpor …
- 世界の茶エキス市場：用途別（食品、飲料、医薬品、化粧品）、カテゴリー別（オーガニック、従来型）、フォーム別（液体および粉末）、種類別（緑茶、紅茶、ウーロン茶）、地域別The tea extracts market is projected to grow at a CAGR of 6.9% from 2019 to 2025. The global tea extracts market is estimated to be valued at USD 2.5 billion in 2019 and is projected to reach USD 3.8 billion by 2025, recording a CAGR of 6.9%. The increase in consumption of convenience food, rise in health consciousness among consumers, and multi-functionalities of tea extracts are some of the majo …
- 固体照明および蛍光照明の世界市場：LED、OLED、LFL、CFL、CCFL技術The increasing demand for energy-saving and environmentally-friendly lighting technologies is driving the growth of the global SSL and other energy-efficient lighting systems market. The advancement in optoelectronics has revolutionized the lighting market and led to the introduction of highly efficient technologies such as LED and OLED. Environmental concerns have an impact on the market for conv …
- グローバルLNG（液化天然ガス）市場：Global LNG MarketLiquefied natural gas or LNG is natural gas that has been processed to remove either valuable components e.g. helium, or those impurities that could cause difficulty downstream. LNG offers an energy density comparable to petrol and diesel fuels and produces less pollution, but its relatively high cost of production and the need to store it in expensive cryogenic tanks have prevented its widespread …
- 心臓除細動器（医療機器）のグローバル市場（2012-2018）Global Cardiac Defibrillators market value is expected to reach US$10 billion by 2016. The North American segment accounts for nearly 40% (2015) of the global market share while Europe claims approximately 30% (2018). Asia-Pacific is the fastest growing region with a CAGR of 11% driving a market value of US$2.2 billion by 2016. On a global scale, projections for Implantable Cardioverter Defibrilla …
- 世界のトルエンジイソシアネート市場2015The Global Toluene Diisocyanate Industry Report 2015 is a professional and in-depth study on the current state of the Toluene Diisocyanate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Toluene Diisocyanate market analysis is provided for the international markets including development trends, com …
- 航空宇宙産業におけるナノ技術の世界市場2017-2021About Aerospace Nanotechnology Nanostructure, a part of nanotechnology, is a wide and interdisciplinary area requiring R&D, which gained traction in the last two decades. Nanotechnology is defined as the study and the use of structures smaller than 100 nanometers. This technology is capable of transforming the ways in which materials are produced, and the functionalities of the same can be retaine …
- 世界の遺伝子発現解析市場動向及び予測（～2018）Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instrum …
- Thymus Cancer：グローバル臨床試験レビューH2, 2013Thymus Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Thymus Cancer Global Clinical Trials Review, H2, 2013" provides data on the Thymus Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thymus Cancer. It includes an overview of the trial numbers and their recruitment status as per the …
- 世界のBPM（ビジネスプロセス管理）PaaS市場（2014-2018）TechNavio's analysts forecast the Global BPM PaaS market to grow at a CAGR of 21.99 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to reduce the cost of business processes. The Global BPM PaaS market has also been witnessing increased demand for mobile BPM PaaS solutions. However, lack of awareness about the potential of BPM PaaS software c …
